Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Eshelman Fredric N
Relationship:   10% Owner
City:   Wilmington
State:   NC
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   8,151,654    

Indirect Shares

   3,933,809      
Direct Value   $83,566,297    

Indirect Value

   $18,625,640      
Total Shares   12,085,463      
Total Value   $102,191,938      


Bausch Health Companies Inc $271,150 G1 Therapeutics Inc $1,172,500 Eyenovia Inc $1,370,354 Liquidia Technologies Inc $80,752,293 Bausch Health Companies Inc $271,150 G1 Therapeutics Inc $1,172,500 Eyenovia Inc $1,370,354 Liquidia Technologies Inc $80,752,293
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    7   
    3    

     Stock price went up :
    0   
    0    
     Stock price went down :
    7   
    3    
   
     Gain/Loss Ratio :
   -7.0   
   -3.0   
     Percentage Gain/Loss :
   -45.7%
 -43.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmaceutical Product Developme... PPDI Executive Chairman, Di... 2011-12-05 0 2011-12-05 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director, 10% Owner 2014-07-02 0 2014-07-02 0    Premium*  
            Bausch Health Companies Inc BHC Director 2017-05-05 38,298 2016-03-11 0    Premium*  
            G1 Therapeutics Inc GTHX Director, 10% Owner 2017-11-13 250,000 2017-11-13 3,439,151    Premium*  
            Eyenovia Inc EYEN Director 2020-09-11 1,292,787 2020-09-11 319,085    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2020-11-25 6,570,569 2020-11-25 175,573    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PPDI Pharmaceutical Product De... Chief Executive Officer   •       •       •   2004-07-07 4 GD $0.00 $0 D/D 22,000 4,964,263 -
PPDI Pharmaceutical Product De... Chief Executive Officer   •       •       •   2004-07-16 4/A GD $0.00 $0 D/D 22,000 4,964,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-04-04 4 GD $0.00 $0 D/D 7,000 4,957,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-05-18 4 A $0.00 $0 D/D 25,000 4,982,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-05-26 4 OE $6.53 $5,706,592 D/D 380,000 5,362,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-20 4 S $59.96 $9,185,899 D/D (153,000) 5,209,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.51 $3,401,213 D/D (56,989) 5,152,274 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.40 $4,655,153 D/D (77,788) 5,074,486 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.37 $41,500 D/D (699) 5,060,053 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.26 $2,325,274 D/D (38,976) 5,034,811 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-22 4 S $59.02 $1,076,796 D/D (17,947) 4,962,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-22 4 S $59.03 $3,250,299 D/D (54,601) 4,980,210 -
PPDI Pharmaceutical Product De... officerTitle   •       •      –    2005-12-09 4 GD $0.00 $0 D/D 47,000 4,915,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-15 4 S $36.88 $2,016,198 D/D (54,575) 9,577,526 -
PPDI Pharmaceutical Product De... CEO   •       –      –    2006-05-15 4 S $36.45 $7,278,096 D/D (198,425) 9,632,101 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-16 4 S $36.38 $2,293,378 D/D (62,775) 9,442,706 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-16 4 S $36.69 $447,470 D/D (12,180) 9,430,526 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-16 4 S $36.07 $2,608,273 D/D (72,045) 9,505,481 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-18 4 D $35.96 $194,472 D/D (5,408) 9,425,118 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-12-11 4 GD $0.00 $0 D/D 74,492 9,350,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-02-20 4 S $33.49 $842,609 D/D (25,133) 9,267,293 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-02-20 4 S $33.19 $1,942,219 D/D (58,200) 9,292,426 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-02-26 4 S $33.31 $227,184 D/D (6,800) 9,183,960 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-02-26 4 S $32.95 $1,093,070 D/D (33,000) 9,190,760 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-02-26 4 S $32.65 $1,428,192 D/D (43,533) 9,223,760 0 -
  148  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us